Choi Joon Hyuk, Thung Swan N
Department of Pathology, Yeungnam University College of Medicine, Daegu 42415, Republic of Korea.
Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, 1468 Madison Avenue, New York, NY 10029, USA.
Biomedicines. 2023 Sep 20;11(9):2582. doi: 10.3390/biomedicines11092582.
Hepatocellular carcinoma (HCC) is a primary liver cancer characterized by hepatocellular differentiation. HCC is molecularly heterogeneous with a wide spectrum of histopathology. The prognosis of patients with HCC is generally poor, especially in those with advanced stages. HCC remains a diagnostic challenge for pathologists because of its morphological and phenotypic diversity. However, recent advances have enhanced our understanding of the molecular genetics and histological subtypes of HCC. Accurate diagnosis of HCC is important for patient management and prognosis. This review provides an update on HCC pathology, focusing on molecular genetics, histological subtypes, and diagnostic approaches.
肝细胞癌(HCC)是一种以肝细胞分化为特征的原发性肝癌。HCC在分子水平上具有异质性,伴有广泛的组织病理学表现。HCC患者的预后通常较差,尤其是晚期患者。由于其形态学和表型的多样性,HCC对病理学家来说仍然是一个诊断挑战。然而,最近的进展加深了我们对HCC分子遗传学和组织学亚型的理解。准确诊断HCC对患者的管理和预后很重要。本综述提供了HCC病理学的最新进展,重点关注分子遗传学、组织学亚型和诊断方法。